Incyte Corporation (OQ:INCY)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for INCY within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET August 2nd, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jul 17/20 Jul 16/20 Stein Steven H Direct Ownership Common Stock S - Open market or private sale -766 $103.83
Jul 17/20 Jul 15/20 Wenqing Yao Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -639 $104.25
Jul 17/20 Jul 15/20 Trower Paul Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -203 $104.25
Jul 17/20 Jul 15/20 Swain Paula J Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -626 $104.25
Jul 17/20 Jul 15/20 Stein Steven H Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -623 $104.25
Jul 17/20 Jul 15/20 Hoppenot Herve Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -2,420 $104.25
Jul 17/20 Jul 15/20 Flannelly Barry P Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -639 $104.25
Jul 14/20 Jul 13/20 Dhanak Dashyant Direct Ownership Incentive Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -2,419  
Jul 14/20 Jul 13/20 Dhanak Dashyant Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 2,419 $65.42
Jul 14/20 Jul 10/20 Pasquale Maria E Direct Ownership Incentive Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -127  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for INCY within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET August 2nd, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Jul 17/20 Jul 15/20 Wenqing Yao Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -639 $104.25
Jul 17/20 Jul 15/20 Trower Paul Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -203 $104.25
Jul 17/20 Jul 15/20 Swain Paula J Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -626 $104.25
Jul 17/20 Jul 16/20 Stein Steven H Direct Ownership Common Stock S - Open market or private sale -766 $103.83
Jul 17/20 Jul 15/20 Stein Steven H Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -623 $104.25
Jul 17/20 Jul 15/20 Hoppenot Herve Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -2,420 $104.25
Jul 17/20 Jul 15/20 Flannelly Barry P Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -639 $104.25
Jul 14/20 Jul 10/20 Pasquale Maria E Direct Ownership Incentive Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -127  
Jul 14/20 Jul 10/20 Pasquale Maria E Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 127 $65.36
Jul 14/20 Jul 13/20 Dhanak Dashyant Direct Ownership Incentive Stock Option (right to buy) M - Exercise or conversion exempt under rule 16b-3 -2,419  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $INCY

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Moderna (OQ:MRNA)
Biohaven Pharmaceutical H (N:BHVN)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.